Want to join the conversation?
$LYB's asset portfolio continued to demonstrate balance with strong results in 3Q15. Despite the rebalancing of supply/demand in the global ethylene industry and the decline in the price of crude oil since mid-2014 and during 3Q15, asset portfolio generated strong results as some product margins expanded while others contracted.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.